NovaBridge Biosciences Operating Cash Flow
NovaBridge Biosciences (NBP) reported Operating Cash Flow of -CNY 1.30 billion for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-04-30
- NovaBridge Biosciences net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was 1.02B CNY.
- NovaBridge Biosciences net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was -215.99M CNY.
CNY
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | -1.30B CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | -1.10B CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | -571.16M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | -973.09M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | -442.64M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 1.02B CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 433.56M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | -582.63M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | -215.99M CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | -867.98M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | -651.99M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | -280.70M CNY 20-F · filed 2021-04-28 | |||
| 2017-12-31 | -252.16M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$183.80M 20-F · filed 2024-04-30 | |||
| 2022-12-31 | -$159.89M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | -$85.27M 6-K · filed 2022-11-10 | |||
| 2021-12-31 | -$152.70M 20-F · filed 2022-04-29 | |||
| 2020-12-31 | $152.26M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $66.45M 20-F · filed 2021-04-28 | ||
| 2020-09-30 | -$85.81M 6-K · filed 2021-02-05 | |||
| 2019-12-31 | -$124.68M 20-F · filed 2020-04-29 |